The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders Amongst the Psoriatic Patients
Journal of Clinical Medicine
doi 10.3390/jcm8122206
Full Text
Open PDFAbstract
Available in full text
Date
December 13, 2019
Authors
Publisher
MDPI AG